Screening Marine Microbial Metabolites as Promising Inhibitors of Borrelia garinii: A Structural Docking Approach towards Developing Novel Lyme Disease Treatment

Figure 7

Nonpromiscuous ligands used for inhibition analysis. 1: CMNPD18759; 2: CMNPD24419; 3: CMNPD24876; 4: CMNPD8737; 5: CMNPD23643. Identified from Hit Dexter 3 (URL: https://nerdd.univie.ac.at/hitdexter3/; accessed on 18 September 2023).